NCT02465060
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial) screening 2 active_not_recruiting NCT04320888
Selpercatinib for the Treatment of Advanced Solid Tumors, Lymphomas, or Histiocytic Disorders With Activating RET Gene Alterations, a Pediatric MATCH Treatment Trial treatment 2 active_not_recruiting NCT04870944
CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma No drug interventions treatment 1 / 2 recruiting NCT01790152
Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment No drug interventions Not Available Not Available recruiting NCT04500548
Testing the Combination of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) in Children, Adolescent, and Young Adult Patients With Relapsed/Refractory Cancers That Have an Increased Number of Genetic Changes, The 3CI Study treatment 1 withdrawn NCT02780804
Entinostat in Treating Pediatric Patients With Recurrent or Refractory Solid Tumors treatment 1 completed NCT03418038
Ascorbic Acid and Chemotherapy for the Treatment of Relapsed or Refractory Lymphoma, CCUS, and Chronic Myelomonocytic Leukemia treatment 2 recruiting NCT03291938
IACS-010759 in Advanced Cancers No drug interventions treatment 1 completed NCT05663502
Collecting Blood and Tissue Sample Donations for Research for HIV/AIDS-Related Cancers No drug interventions Not Available Not Available recruiting NCT03229278
Trigriluzole With Nivolumab and Pembrolizumab in Treating Patients With Metastatic or Unresectable Solid Malignancies or Lymphoma treatment 1 completed NCT05071209
Elimusertib for the Treatment of Relapsed or Refractory Solid Tumors treatment 1 / 2 active_not_recruiting NCT02343718
Vinblastine and Temsirolimus in Pediatrics With Recurrent or Refractory Lymphoma or Solid Tumours Including CNS Tumours treatment 1 completed NCT04090619
Frequency of Cachexia in Ambulatory Cancer Patients and Psychological Burden in Patients and Their Primary Caregivers No drug interventions Not Available Not Available active_not_recruiting NCT03323034
Pevonedistat, Irinotecan, and Temozolomide in Treating Patients With Recurrent or Refractory Solid Tumors or Lymphoma treatment 1 active_not_recruiting NCT02323880
Selinexor in Treating Younger Patients With Recurrent or Refractory Solid Tumors or High-Grade Gliomas treatment 1 active_not_recruiting